NL1026438A1 - Nieuwe verbindingen. - Google Patents

Nieuwe verbindingen.

Info

Publication number
NL1026438A1
NL1026438A1 NL1026438A NL1026438A NL1026438A1 NL 1026438 A1 NL1026438 A1 NL 1026438A1 NL 1026438 A NL1026438 A NL 1026438A NL 1026438 A NL1026438 A NL 1026438A NL 1026438 A1 NL1026438 A1 NL 1026438A1
Authority
NL
Netherlands
Prior art keywords
new connections
connections
new
Prior art date
Application number
NL1026438A
Other languages
English (en)
Other versions
NL1026438C2 (nl
Inventor
Paul Vincent Fish
Michael Jonathan Fray
Deborah Jane Lovering
Alan Stobie
Florian Wakenhut
Gavin Alistair Whitlock
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0314048.0A external-priority patent/GB0314048D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of NL1026438A1 publication Critical patent/NL1026438A1/nl
Application granted granted Critical
Publication of NL1026438C2 publication Critical patent/NL1026438C2/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NL1026438A 2003-06-17 2004-06-17 Nieuwe verbindingen. NL1026438C2 (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0314048 2003-06-17
GBGB0314048.0A GB0314048D0 (en) 2003-06-17 2003-06-17 Novel compounds
US49312603P 2003-08-06 2003-08-06
US49312603 2003-08-06

Publications (2)

Publication Number Publication Date
NL1026438A1 true NL1026438A1 (nl) 2004-12-20
NL1026438C2 NL1026438C2 (nl) 2005-09-20

Family

ID=33554153

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1026438A NL1026438C2 (nl) 2003-06-17 2004-06-17 Nieuwe verbindingen.

Country Status (31)

Country Link
US (2) US7378436B2 (nl)
EP (1) EP1638933B1 (nl)
JP (1) JP4137159B2 (nl)
KR (1) KR100803796B1 (nl)
AP (1) AP2005003467A0 (nl)
AR (1) AR044715A1 (nl)
AT (1) ATE398107T1 (nl)
AU (1) AU2004247487B2 (nl)
BR (1) BRPI0411594A (nl)
CA (1) CA2530159C (nl)
CY (1) CY1110434T1 (nl)
DE (1) DE602004014372D1 (nl)
DK (1) DK1638933T3 (nl)
EA (1) EA009881B1 (nl)
EC (1) ECSP056232A (nl)
ES (1) ES2305776T3 (nl)
HR (2) HRP20050993A2 (nl)
IL (1) IL172063A0 (nl)
IS (1) IS8136A (nl)
MA (1) MA27885A1 (nl)
MX (1) MXPA05013960A (nl)
NL (1) NL1026438C2 (nl)
NZ (1) NZ544046A (nl)
PA (1) PA8605301A1 (nl)
PE (1) PE20050631A1 (nl)
PL (1) PL1638933T3 (nl)
PT (1) PT1638933E (nl)
SI (1) SI1638933T1 (nl)
TW (1) TW200505852A (nl)
UY (1) UY28360A1 (nl)
WO (1) WO2004110995A1 (nl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60133203T3 (de) 2000-07-31 2012-02-23 Nycomed Danmark Aps Fentanyl Zusammensetzung für nasale Anwendung
EA009881B1 (ru) * 2003-06-17 2008-04-28 Пфайзер Инк. Производные n-пирролидин-3-ил-амида в качестве ингибиторов обратного захвата серотонина и норадреналина
EP1805165B1 (en) 2004-10-18 2009-12-16 Eli Lilly And Company 1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mglur3 receptor antagonists
US7122683B2 (en) 2004-11-23 2006-10-17 Pfizer Inc. Amides useful as monoamine re-uptake inhibitors
GB0425766D0 (en) * 2004-11-23 2004-12-22 Pfizer Ltd Novel compounds
WO2006064336A2 (en) * 2004-12-14 2006-06-22 Pfizer Limited N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
US20090239929A1 (en) * 2004-12-14 2009-09-24 Paul Vincent Fish N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors
TWI410406B (zh) 2005-05-13 2013-10-01 Otsuka Pharma Co Ltd 吡咯烷化合物
ATE445612T1 (de) * 2005-06-02 2009-10-15 Hoffmann La Roche Piperidin-4-yl-amidderivate und ihre verwendung als antagonisten des sst-rezeptors vom subtyp 5
WO2007135530A2 (en) * 2006-05-22 2007-11-29 Pfizer Limited Pharmaceutically & veterinarily suitable salt
US20080014152A1 (en) * 2006-07-13 2008-01-17 Di Mauro Thomas M Intranasal delivery of clenbuterol across the cribriform plate and into the brain
JP5219465B2 (ja) * 2006-11-10 2013-06-26 大塚製薬株式会社 医薬
WO2008093737A1 (ja) * 2007-01-31 2008-08-07 Dainippon Sumitomo Pharma Co., Ltd. アミド誘導体
JP2010189275A (ja) * 2007-06-14 2010-09-02 Dainippon Sumitomo Pharma Co Ltd ナフタレン誘導体
US8263652B2 (en) 2007-10-31 2012-09-11 Sk Biopharmaceuticals Co., Ltd. Stabilized pediatric suspension of carisbamate
TWI434690B (zh) * 2007-12-19 2014-04-21 Dainippon Sumitomo Pharma Co 雜雙環衍生物
ES2434250T3 (es) * 2008-07-24 2013-12-16 Theravance, Inc. Compuestos de 3-(fenoxifenilmetil)pirrolidina
MX2011005089A (es) 2008-11-14 2011-07-29 Theravance Inc Compuestos de 4-[2-(2-fluorofenoximetil)fenil]piperidina.
WO2010120910A1 (en) * 2009-04-15 2010-10-21 Theravance, Inc. 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
CA2765527A1 (en) 2009-06-24 2010-12-29 Satoshi Suetsugu N-substituted-cyclic amino derivative
MX2012000685A (es) * 2009-07-13 2012-02-28 Theravance Inc Compuesto de 3-fenoximetilpirrolidina.
US8273786B2 (en) * 2009-07-21 2012-09-25 Theravance, Inc. 3-phenoxymethylpyrrolidine compounds
JP5705239B2 (ja) 2010-01-11 2015-04-22 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー セロトニンおよびノルエピネフリン再取込みインヒビターとしての1−(2−フェノキシメチルフェニル)ピペラジン化合物
JP5769348B2 (ja) * 2010-03-22 2015-08-26 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー 1−(2−フェノキシメチルヘテロアリール)ピペリジン化合物および1−(2−フェノキシメチルヘテロアリール)ピペラジン化合物
WO2012051103A1 (en) 2010-10-11 2012-04-19 Theravance, Inc. Serotonin reuptake inhibitors
US8501964B2 (en) 2010-12-03 2013-08-06 Theravance, Inc. Serotonin reuptake inhibitors

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE138773C (nl)
US3963745A (en) * 1972-04-03 1976-06-15 A. H. Robins Company, Incorporated Method for controlling emesis with N-(1-substituted-3-pyrrolidinyl)benzamides and thiobenzamides
US4002757A (en) * 1974-12-26 1977-01-11 A. H. Robins Company, Incorporated N-(1-substituted-3-pyrrolidinyl)-4-quinolinecarboxamides
US4020072A (en) 1976-05-04 1977-04-26 E. R. Squibb & Sons, Inc. 5-Aminomethyl-1H-pyrazolo[3,4-b]pyridines
GB1574419A (en) * 1977-11-11 1980-09-03 Anphar Sa Piperidine compounds
CH628885A5 (en) * 1978-01-01 1982-03-31 Anphar Sa Piperidine derivative
US5130312A (en) * 1987-07-17 1992-07-14 Janssen Pharmaceutica N.V. Substituted N-(3-hydroxy-4-piperidinyl)benzamides
FR2642069B1 (fr) 1989-01-20 1991-04-12 Rhone Poulenc Sante Nouveaux derives du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1997018813A1 (en) 1995-11-22 1997-05-29 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU4167099A (en) 1998-06-19 2000-01-05 Nissan Chemical Industries Ltd. Heterocyclic compounds as hypoglycemic agents
US6670299B1 (en) * 1999-07-03 2003-12-30 Northwestern University Cyclopentadienyl-containing low-valent early transition metal olefin polymerization catalysts
FR2802206B1 (fr) 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
JP2003525903A (ja) 2000-03-03 2003-09-02 エーザイ株式会社 コリンエステラーゼ阻害剤の新規使用法
JP4664564B2 (ja) * 2000-03-06 2011-04-06 アカディア ファーマシューティカルズ,インコーポレーテッド セロトニン関連疾患の治療に使用する含窒素環式化合物
AU2001287898A1 (en) 2000-09-22 2002-04-02 Stephen Garland Pyrazolopyridines and pyrazolopyridazines as antidiabetics
WO2002024649A1 (en) 2000-09-25 2002-03-28 Actelion Pharmaceuticals Ltd Substituted amino-aza-cycloalkanes useful against malaria
ATE479655T1 (de) 2001-09-14 2010-09-15 High Point Pharmaceuticals Llc Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
EP1442018A1 (en) 2001-10-31 2004-08-04 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Novel anticancer compounds
GB0128287D0 (en) 2001-11-26 2002-01-16 Smithkline Beecham Plc Novel method and compounds
CA2490397A1 (en) * 2002-06-24 2003-12-31 Acadia Pharmaceuticals Inc. N-substituted piperidine derivatives as serotonin receptor agents
WO2004009549A2 (en) 2002-07-18 2004-01-29 Actelion Pharmaceuticals Ltd Piperidines useful for the treatment of central nervous system disorders
AU2003263393A1 (en) 2002-09-04 2004-03-29 Glenmark Pharmaceuticals Limited New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
KR101061352B1 (ko) 2002-12-20 2011-08-31 케모센트릭스 인간 종양-발현된 ccxckr2의 저해물질
EA009881B1 (ru) * 2003-06-17 2008-04-28 Пфайзер Инк. Производные n-пирролидин-3-ил-амида в качестве ингибиторов обратного захвата серотонина и норадреналина

Also Published As

Publication number Publication date
ECSP056232A (es) 2006-04-19
TW200505852A (en) 2005-02-16
KR20060036927A (ko) 2006-05-02
HRP20050993A2 (en) 2006-03-31
BRPI0411594A (pt) 2006-08-29
ES2305776T3 (es) 2008-11-01
KR100803796B1 (ko) 2008-02-14
HRP20080339T3 (en) 2008-08-31
EA009881B1 (ru) 2008-04-28
US20080306123A1 (en) 2008-12-11
MA27885A1 (fr) 2006-05-02
PE20050631A1 (es) 2005-09-14
WO2004110995A8 (en) 2005-04-21
SI1638933T1 (sl) 2008-10-31
WO2004110995A1 (en) 2004-12-23
CY1110434T1 (el) 2015-04-29
EA200501730A1 (ru) 2006-08-25
PA8605301A1 (es) 2005-02-04
JP4137159B2 (ja) 2008-08-20
AP2005003467A0 (en) 2006-12-31
UY28360A1 (es) 2005-01-31
AR044715A1 (es) 2005-09-21
AU2004247487A1 (en) 2004-12-23
US20050137229A1 (en) 2005-06-23
EP1638933B1 (en) 2008-06-11
US7378436B2 (en) 2008-05-27
DK1638933T3 (da) 2008-07-28
ATE398107T1 (de) 2008-07-15
NZ544046A (en) 2009-08-28
CA2530159C (en) 2010-02-02
CA2530159A1 (en) 2004-12-23
AU2004247487B2 (en) 2010-05-20
NL1026438C2 (nl) 2005-09-20
PL1638933T3 (pl) 2008-10-31
DE602004014372D1 (de) 2008-07-24
IS8136A (is) 2005-11-21
JP2006527758A (ja) 2006-12-07
EP1638933A1 (en) 2006-03-29
MXPA05013960A (es) 2006-02-24
IL172063A0 (en) 2009-02-11
PT1638933E (pt) 2008-07-22

Similar Documents

Publication Publication Date Title
NL1028927A1 (nl) Nieuwe verbindingen.
NO20032883L (no) Bolgekraftverk.
NO20041144L (no) Gassloftingsventil.
NL1026438A1 (nl) Nieuwe verbindingen.
NL1026074A1 (nl) Nieuwe Farmaceutica.
NL1027568A1 (nl) Nieuwe farmaceutica.
NL1026716A1 (nl) Verbindingen.
FR2855029B1 (fr) Cache-pot.
NL1026932A1 (nl) Verlichtingseenheid.
LU91032B1 (de) Mauerstein.
NO20040394L (no) Fullpumpesentreringsstotte.
ITMI20031078A1 (it) Copridivano.
ITGE20030068A1 (it) Termoalgometro.
ES1053926Y (es) Andamio multifuncional.
ES1055830Y (es) Mosquitera.
ES1055317Y (es) Escenario autotransportable.
ES1055913Y (es) Linterna.
NL1030485A1 (nl) Nieuwe verbindingen.
ES1055866Y (es) Mopa-fregona.
ES1054894Y (es) Caja-expositor.
ES1053821Y (es) Pasapures.
ES1055854Y (es) Colchon-reposapies.
ES1054091Y (es) Muñeco-diana.
ES1056135Y (es) Lava-pies.
ES1056074Y (es) Portarretratos.

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20050513

PD2B A search report has been drawn up
V1 Lapsed because of non-payment of the annual fee

Effective date: 20120101